{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:36:30Z","timestamp":1790753790977,"version":"4.1.0"},"reference-count":134,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["SRA-17-077"],"award-info":[{"award-number":["SRA-17-077"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81525018"],"award-info":[{"award-number":["81525018"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI144008"],"award-info":[{"award-number":["R01 AI144008"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.antiviral.2020.104898","type":"journal-article","created":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T20:20:13Z","timestamp":1596486013000},"page":"104898","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Animal models for the study of human hepatitis B and D virus infection: New insights and progress"],"prefix":"10.1016","volume":"182","author":[{"given":"Benjamin J.","family":"Burwitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongmin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2020.104898_bib1","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.jhep.2016.02.012","article-title":"Experimental in vitro and in vivo models for the study of human hepatitis B virus infection","volume":"64","author":"Allweiss","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104898_bib2","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/infdis\/jiy355","article-title":"The loss-of-function S267F variant in HBV receptor NTCP reduces human risk for HBV infection and disease progression","volume":"218","author":"An","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104898_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1073\/pnas.86.1.207","article-title":"Expression and replication of hepatitis B virus genome in transgenic mice","volume":"86","author":"Araki","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104898_bib4","doi-asserted-by":"crossref","first-page":"9652","DOI":"10.1128\/JVI.00867-09","article-title":"The size of the viral inoculum contributes to the outcome of hepatitis B virus infection","volume":"83","author":"Asabe","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104898_bib5","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nbt1326","article-title":"Robust expansion of human hepatocytes in Fah-\/-\/Rag2-\/-\/Il2rg-\/- mice","volume":"25","author":"Azuma","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.antiviral.2020.104898_bib6","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/infdis\/127.6.648","article-title":"Transmission of type B viral hepatitis to chimpanzees","volume":"127","author":"Barker","year":"1973","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104898_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004032","article-title":"Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages","volume":"10","author":"Bility","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104898_bib8","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jhep.2016.04.022","article-title":"Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells","volume":"65","author":"Billerbeck","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104898_bib9","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1172\/JCI40094","article-title":"Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment","volume":"120","author":"Bissig","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2020.104898_bib10","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jama.1965.03080070025007","article-title":"A \"new\" antigen in leukemia sera","volume":"191","author":"Blumberg","year":"1965","journal-title":"Jama"},{"key":"10.1016\/j.antiviral.2020.104898_bib11","first-page":"1566","article-title":"Hepatitis and leukemia: their relation to Australia antigen","volume":"44","author":"Blumberg","year":"1968","journal-title":"Bull. N. Y. Acad. Med."},{"key":"10.1016\/j.antiviral.2020.104898_bib12","doi-asserted-by":"crossref","first-page":"7665","DOI":"10.3748\/wjg.v20.i24.7665","article-title":"Hepatitis B virus lineages in mammalian hosts: potential for bidirectional cross-species transmission","volume":"20","author":"Bonvicino","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2020.104898_bib13","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1038\/s41467-017-01953-y","article-title":"Hepatocytic expression of human sodium-taurocholate cotransporting polypeptide enables hepatitis B virus infection of macaques","volume":"8","author":"Burwitz","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2020.104898_bib14","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1128\/jvi.71.4.3236-3243.1997","article-title":"Interleukin-12 inhibits hepatitis B virus replication in transgenic mice","volume":"71","author":"Cavanaugh","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104898_bib15","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1128\/JVI.72.4.2630-2637.1998","article-title":"Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic mice","volume":"72","author":"Cavanaugh","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104898_bib16","series-title":"Unmet Needs in Basic Research: in Vitro and in Vivo Models, Hepatitis B Virus and Liver Disease","author":"Chayama","year":"2018"},{"key":"10.1016\/j.antiviral.2020.104898_bib17","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/hep4.1471","article-title":"Woolly monkey-HBV infection in squirrel monkeys as a surrogate nonhuman primate model of HBV infection","volume":"4","author":"Chen","year":"2020","journal-title":"Hepatology communications"},{"key":"10.1016\/j.antiviral.2020.104898_bib18","first-page":"1316","article-title":"Hepatitis B virus transgenic mice: insights into the virus and the disease","volume":"22","author":"Chisari","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104898_bib19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3109\/00498254.2010.523736","article-title":"Differential effect of genetic variants of Na(+)-taurocholate co-transporting polypeptide (NTCP) and organic anion-transporting polypeptide 1B1 (OATP1B1) on the uptake of HMG-CoA reductase inhibitors","volume":"41","author":"Choi","year":"2011","journal-title":"Xenobiotica; the fate of foreign compounds in biological systems"},{"key":"10.1016\/j.antiviral.2020.104898_bib20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.antiviral.2013.10.019","article-title":"Lentiviral backbone-based hepatitis B virus replicon-mediated transfer favours the establishment of persistent hepatitis B virus infection in mice after hydrodynamic injection","volume":"101","author":"Chuai","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104898_bib21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12881-019-0823-x","article-title":"Association of NTCP polymorphisms with clinical outcome of hepatitis B infection in Thai individuals","volume":"20","author":"Chuaypen","year":"2019","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.antiviral.2020.104898_bib22","doi-asserted-by":"crossref","first-page":"9021","DOI":"10.1128\/JVI.01261-15","article-title":"Hepatitis B virus covalently closed circular DNA formation in immortalized mouse hepatocytes associated with nucleocapsid destabilization","volume":"89","author":"Cui","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104898_bib23","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1053\/jhep.2001.23314","article-title":"Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus","volume":"33","author":"Dandri","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104898_bib24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-2006-939760","article-title":"Small animal model systems for studying hepatitis B virus replication and pathogenesis","volume":"26","author":"Dandri","year":"2006","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.antiviral.2020.104898_bib25","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jhep.2011.05.037","article-title":"Chimeric mouse model of hepatitis B virus infection","volume":"56","author":"Dandri","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104898_bib26","first-page":"273","article-title":"Animal models of HBV infection. Best practice & research","volume":"31","author":"Dandri","year":"2017","journal-title":"Clinical gastroenterology"},{"key":"10.1016\/j.antiviral.2020.104898_bib27","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.jhep.2018.01.029","article-title":"A novel hepatitis B virus species discovered in capuchin monkeys sheds new light on the evolution of primate hepadnaviruses","volume":"68","author":"de Carvalho Dominguez Souza","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104898_bib28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00430-014-0378-6","article-title":"Mouse models for therapeutic vaccination against hepatitis B virus","volume":"204","author":"Dembek","year":"2015","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2020.104898_bib29","first-page":"81","article-title":"Infectious patterns of Australia antigenemia and antibodies in chimpanzees","volume":"5","author":"Desmyter","year":"1971","journal-title":"Prog. Immunobiol. Stand."},{"key":"10.1016\/j.antiviral.2020.104898_bib30","doi-asserted-by":"crossref","first-page":"5554","DOI":"10.1128\/JVI.03134-12","article-title":"Adeno-associated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules","volume":"87","author":"Dion","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104898_bib31","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/hep.26428","article-title":"Discovery of naturally occurring transmissible chronic hepatitis B virus infection among Macaca fascicularis from Mauritius Island","volume":"58","author":"Dupinay","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104898_bib32","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1089\/hum.2005.16.1168","article-title":"Efficient in vivo xenogeneic retroviral vector-mediated gene transduction into human hepatocytes","volume":"16","author":"Emoto","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.antiviral.2020.104898_bib33","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1128\/jvi.62.11.4144-4152.1988","article-title":"Replication and gene expression of hepatitis B virus in a transgenic mouse that contains the complete viral genome","volume":"62","author":"Farza","year":"1988","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104898_bib34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1128\/jvi.41.1.51-65.1982","article-title":"Nucleotide sequence of a cloned woodchuck hepatitis virus genome: comparison with the hepatitis B virus sequence","volume":"41","author":"Galibert","year":"1982","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104898_bib35","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1101\/gad.7.12a.2298","article-title":"Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice","volume":"7","author":"Grompe","year":"1993","journal-title":"Gene Dev."},{"key":"10.1016\/j.antiviral.2020.104898_bib36","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ng0895-453","article-title":"Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I","volume":"10","author":"Grompe","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.antiviral.2020.104898_bib37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1074-7613(00)80295-2","article-title":"Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes","volume":"4","author":"Guidotti","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2020.104898_bib38","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1128\/jvi.69.10.6158-6169.1995","article-title":"High-level hepatitis B virus replication in transgenic mice","volume":"69","author":"Guidotti","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104898_bib39","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1128\/JVI.76.6.2617-2621.2002","article-title":"Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice","volume":"76","author":"Guidotti","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104898_bib40","doi-asserted-by":"crossref","first-page":"25552","DOI":"10.1038\/srep25552","article-title":"The recombined cccDNA produced using minicircle technology mimicked HBV genome in structure and function closely","volume":"6","author":"Guo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2020.104898_bib41","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000149651","article-title":"Taxonomic classification of human hepatitis B virus","volume":"25","author":"Gust","year":"1986","journal-title":"Intervirology"},{"key":"10.1016\/j.antiviral.2020.104898_bib42","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1172\/JCI117091","article-title":"Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+\/bile acid cotransporter","volume":"93","author":"Hagenbuch","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2020.104898_bib43","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1128\/JVI.01936-06","article-title":"Adenovirus infection triggers a rapid, MyD88-regulated transcriptome response critical to acute-phase and adaptive immune responses in vivo","volume":"81","author":"Hartman","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104898_bib44","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.bbrc.2011.01.042","article-title":"The reconstituted 'humanized liver' in TK-NOG mice is mature and functional","volume":"405","author":"Hasegawa","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2020.104898_bib45","doi-asserted-by":"crossref","first-page":"8866","DOI":"10.1128\/JVI.00901-16","article-title":"Modification of three amino acids in sodium taurocholate cotransporting polypeptide renders mice susceptible to infection with hepatitis D virus in vivo","volume":"90","author":"He","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104898_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004840","article-title":"Hepatitis D virus infection of mice expressing human sodium taurocholate Co-transporting polypeptide","volume":"11","author":"He","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104898_bib47","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0092-8674(90)90010-C","article-title":"Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator","volume":"62","author":"Heckel","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2020.104898_bib48","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1600-0684.2001.300102.x","article-title":"Prevalence of hepatitis B virus infections in nonhuman primates","volume":"30","author":"Heckel","year":"2001","journal-title":"J. Med. Primatol."},{"key":"10.1016\/j.antiviral.2020.104898_bib49","first-page":"1","article-title":"An outbreak of infectious hepatitis among chimpanzee handlers at a United States Air Force Base. Project report","volume":"61","author":"Hillis","year":"1961","journal-title":"USAF School of Aviation Medicine"},{"key":"10.1016\/j.antiviral.2020.104898_bib50","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1537-2995.1963.tb04673.x","article-title":"Viral hepatitis associated with sub-human primates","volume":"3","author":"Hillis","year":"1963","journal-title":"Transfusion"},{"key":"10.1016\/j.antiviral.2020.104898_bib51","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.1074\/jbc.M305782200","article-title":"Ethnicity-dependent polymorphism in Na+-taurocholate cotransporting polypeptide (SLC10A1) reveals a domain critical for bile acid substrate recognition","volume":"279","author":"Ho","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104898_bib52","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1136\/gutjnl-2015-310686","article-title":"The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B","volume":"65","author":"Hu","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2020.104898_bib53","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/j.gastro.2018.06.093","article-title":"Cell and animal models for studying hepatitis B virus infection and drug development","volume":"156","author":"Hu","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2020.104898_bib54","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1053\/j.gastro.2012.03.006","article-title":"Transfer of HBV genomes using low doses of adenovirus vectors leads to persistent infection in immune competent mice","volume":"142","author":"Huang","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2020.104898_bib55","doi-asserted-by":"crossref","first-page":"17862","DOI":"10.1073\/pnas.0608578103","article-title":"An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection","volume":"103","author":"Huang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104898_bib56","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021477","article-title":"Mouse models of hepatitis B virus pathogenesis","volume":"5","author":"Iannacone","year":"2015","journal-title":"Cold Spring Harbor perspectives in medicine"},{"key":"10.1016\/j.antiviral.2020.104898_bib57","doi-asserted-by":"crossref","first-page":"7269","DOI":"10.1128\/JVI.79.11.7269-7272.2005","article-title":"Toll-like receptor signaling inhibits hepatitis B virus replication in vivo","volume":"79","author":"Isogawa","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104898_bib58","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1053\/he.2000.5982","article-title":"Treatment of chronic woodchuck hepatitis virus infection in the Eastern woodchuck (Marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans","volume":"31","author":"Korba","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104898_bib59","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bbrc.2013.10.040","article-title":"A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections","volume":"441","author":"Kosaka","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2020.104898_bib60","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00430-014-0379-5","article-title":"Therapeutic vaccination and immunomodulation in the treatment of chronic hepatitis B: preclinical studies in the woodchuck","volume":"204","author":"Kosinska","year":"2015","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2020.104898_bib61","doi-asserted-by":"crossref","first-page":"7814","DOI":"10.1128\/JVI.77.14.7814-7819.2003","article-title":"An infectious clone of woolly monkey hepatitis B virus","volume":"77","author":"Lanford","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104898_bib62","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1073\/pnas.95.10.5757","article-title":"Isolation of a hepadnavirus from the woolly monkey, a New World primate","volume":"95","author":"Lanford","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104898_bib63","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/ilar\/ilx028","article-title":"The chimpanzee model of viral hepatitis: advances in understanding the immune response and treatment of viral hepatitis","volume":"58","author":"Lanford","year":"2017","journal-title":"ILAR J."},{"key":"10.1016\/j.antiviral.2020.104898_bib64","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jhep.2015.10.030","article-title":"Evidence that hepatitis B virus replication in mouse cells is limited by the lack of a host cell dependency factor","volume":"64","author":"Lempp","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104898_bib65","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1128\/JVI.02832-15","article-title":"Hepatitis B virus infection of a mouse hepatic cell line reconstituted with human sodium taurocholate cotransporting polypeptide","volume":"90","author":"Lempp","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104898_bib66","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/hep.29112","article-title":"Sodium taurocholate cotransporting polypeptide is the limiting host factor of hepatitis B virus infection in macaque and pig hepatocytes","volume":"66","author":"Lempp","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104898_bib67","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/hep.29406","article-title":"Recombinant covalently closed circular DNA of hepatitis B virus induces long-term viral persistence with chronic hepatitis in a mouse model","volume":"67","author":"Li","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104898_bib68","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/cmi.2013.66","article-title":"HBV life cycle is restricted in mouse hepatocytes expressing human NTCP","volume":"11","author":"Li","year":"2014","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.antiviral.2020.104898_bib69","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/224810a0","article-title":"Chimpanzee antibodies to Australia antigen","volume":"224","author":"Lichter","year":"1969","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2020.104898_bib70","doi-asserted-by":"crossref","first-page":"e186","DOI":"10.1038\/mtna.2014.38","article-title":"The CRISPR\/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo. Molecular therapy","volume":"3","author":"Lin","year":"2014","journal-title":"Nucleic acids"},{"key":"10.1016\/j.antiviral.2020.104898_bib71","doi-asserted-by":"crossref","first-page":"a021360","DOI":"10.1101\/cshperspect.a021360","article-title":"Origins and evolution of hepatitis B virus and hepatitis D virus","volume":"6","author":"Littlejohn","year":"2016","journal-title":"Cold Spring Harbor perspectives in medicine"},{"key":"10.1016\/j.antiviral.2020.104898_bib72","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/infdis\/125.4.382","article-title":"Serial transmission in rhesus monkeys of an agent related to hepatitis-associated antigen","volume":"125","author":"London","year":"1972","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104898_bib73","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000050039","article-title":"Evaluation of new approaches to prophylactic and therapeutic vaccinations against hepatitis B viruses in the woodchuck model","volume":"44","author":"Lu","year":"2001","journal-title":"Intervirology"},{"key":"10.1016\/j.antiviral.2020.104898_bib74","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.antiviral.2017.07.006","article-title":"Detection of the hepatitis B virus (HBV) covalently-closed-circular DNA (cccDNA) in mice transduced with a recombinant AAV-HBV vector","volume":"145","author":"Lucifora","year":"2017","journal-title":"Antivir. Res."},{"issue":"SUPPLEMENT 1","key":"10.1016\/j.antiviral.2020.104898_bib75","article-title":"Murine hepatocytes with humanized sodium taurocholat polypeptide (NTCP) limit HDV infection in vivo independent of adaptive immune responses","volume":"68","author":"Luetgehmann","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104898_bib77","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/237514a0","article-title":"Experimental infection of chimpanzees with the virus of hepatitis B","volume":"237","author":"Maynard","year":"1972","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2020.104898_bib78","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1128\/JVI.74.5.2255-2264.2000","article-title":"Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines","volume":"74","author":"McClary","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104898_bib79","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3748\/wjg.v13.i1.104","article-title":"The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection","volume":"13","author":"Menne","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2020.104898_bib80","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/hep.20657","article-title":"Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera","volume":"41","author":"Meuleman","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104898_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199200","article-title":"Characterisation of the hepatitis B virus cross-species transmission pattern via Na+\/taurocholate co-transporting polypeptides from 11 New World and Old World primate species","volume":"13","author":"Muller","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2020.104898_bib82","doi-asserted-by":"crossref","first-page":"27782","DOI":"10.1038\/srep27782","article-title":"Sodium taurocholate cotransporting polypeptide inhibition efficiently blocks hepatitis B virus spread in mice with a humanized liver","volume":"6","author":"Nakabori","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2020.104898_bib84","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1021\/acsinfecdis.8b00223","article-title":"In vivo model systems for hepatitis B virus research","volume":"5","author":"Ortega-Prieto","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104898_bib85","first-page":"1273","article-title":"Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes","volume":"151","author":"Overturf","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.antiviral.2020.104898_bib86","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3109\/00498254.2011.555567","article-title":"Genetic polymorphisms in Na+-taurocholate co-transporting polypeptide (NTCP) and ileal apical sodium-dependent bile acid transporter (ASBT) and ethnic comparisons of functional variants of NTCP among Asian populations","volume":"41","author":"Pan","year":"2011","journal-title":"Xenobiotica; the fate of foreign compounds in biological systems"},{"key":"10.1016\/j.antiviral.2020.104898_bib87","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/hep.27608","article-title":"The p.Ser267Phe variant in SLC10A1 is associated with resistance to chronic hepatitis B","volume":"61","author":"Peng","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104898_bib88","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.3748\/wjg.v21.i12.3527","article-title":"High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H\/HeN mice","volume":"21","author":"Peng","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2020.104898_bib89","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1073\/pnas.88.4.1217","article-title":"Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation","volume":"88","author":"Ponder","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104898_bib90","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0016-5085(71)80093-8","article-title":"Role of serum hepatitis virus in chronic liver disease","volume":"60","author":"Prince","year":"1971","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2020.104898_bib91","doi-asserted-by":"crossref","first-page":"8045","DOI":"10.1128\/JVI.01024-14","article-title":"Recombinant covalently closed circular hepatitis B virus DNA induces prolonged viral persistence in immunocompetent mice","volume":"88","author":"Qi","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104898_bib92","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01255-18","article-title":"Robust human and murine hepatocyte culture models of hepatitis B virus infection and replication","volume":"92","author":"Qiao","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104898_bib93","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1128\/JCM.02340-10","article-title":"Improved method for rapid and efficient determination of genome replication and protein expression of clinical hepatitis B virus isolates","volume":"49","author":"Qin","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2020.104898_bib94","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1128\/JVI.75.6.2900-2911.2001","article-title":"Nuclear covalently closed circular viral genomic DNA in the liver of hepatocyte nuclear factor 1 alpha-null hepatitis B virus transgenic mice","volume":"75","author":"Raney","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104898_bib95","doi-asserted-by":"crossref","first-page":"4942","DOI":"10.1073\/pnas.92.11.4942","article-title":"Complete reconstitution of mouse liver with xenogeneic hepatocytes","volume":"92","author":"Rhim","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104898_bib96","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.med.45.1.297","article-title":"Molecular events in the pathogenesis of hepadnavirus-associated hepatocellular carcinoma","volume":"45","author":"Robinson","year":"1994","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.antiviral.2020.104898_bib97","article-title":"The woodchuck, a nonprimate model for immunopathogenesis and therapeutic immunomodulation in chronic hepatitis B virus infection","volume":"5","author":"Roggendorf","year":"2015","journal-title":"Cold Spring Harbor perspectives in medicine"},{"key":"10.1016\/j.antiviral.2020.104898_bib98","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0092-8674(91)90615-6","article-title":"Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene","volume":"66","author":"Sandgren","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2020.104898_bib99","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/095632029901000301","article-title":"Cell-based and animal models for hepatitis B and C viruses","volume":"10","author":"Schinazi","year":"1999","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.antiviral.2020.104898_bib100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1128\/MMBR.64.1.51-68.2000","article-title":"Hepatitis B virus biology","volume":"64","author":"Seeger","year":"2000","journal-title":"Microbiol. Mol. Biol. Rev. : MMBR (Microbiol. Mol. Biol. Rev.)"},{"key":"10.1016\/j.antiviral.2020.104898_bib101","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0042-6822(90)90158-N","article-title":"Hepatitis B virus propagated in a rat hepatoma cell line is infectious in a primate model","volume":"179","author":"Shih","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104898_bib102","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.1073\/pnas.86.16.6323","article-title":"In vitro propagation of human hepatitis B virus in a rat hepatoma cell line","volume":"86","author":"Shih","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104898_bib103","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF00548525","article-title":"Viral hepatitis in subhuman primates and its relationship to human viral hepatitis","volume":"348","author":"Smetana","year":"1969","journal-title":"Virchows Arch. A Pathol.\/Pathol. Anat."},{"key":"10.1016\/j.antiviral.2020.104898_bib104","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.2353\/ajpath.2009.090349","article-title":"A mouse model of inducible liver injury caused by tet-on regulated urokinase for studies of hepatocyte transplantation","volume":"175","author":"Song","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.antiviral.2020.104898_bib105","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1128\/JVI.75.11.5108-5118.2001","article-title":"Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier","volume":"75","author":"Sprinzl","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104898_bib106","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-3-642-14541-4_5","article-title":"The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation","author":"Stieger","year":"2011","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.antiviral.2020.104898_bib107","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jhep.2017.05.010","article-title":"A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-beta induction","volume":"67","author":"Suarez-Amaran","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104898_bib108","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1073\/pnas.75.9.4533","article-title":"A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks","volume":"75","author":"Summers","year":"1978","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104898_bib109","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0002-9440(10)63352-4","article-title":"Near completely humanized liver in mice shows human-type metabolic responses to drugs","volume":"165","author":"Tateno","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.antiviral.2020.104898_bib110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077298","article-title":"Chimeric mouse model for the infection of hepatitis B and C viruses","volume":"8","author":"Tesfaye","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2020.104898_bib111","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/JVI.77.1.68-76.2003","article-title":"CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection","volume":"77","author":"Thimme","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104898_bib112","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nrgastro.2016.37","article-title":"Experimental models of hepatitis B and C - new insights and progress","volume":"13","author":"Thomas","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2020.104898_bib113","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/jgh.12035","article-title":"Immunocompetent nontransgenic mouse models for studying hepatitis B virus immune responses","volume":"28","author":"Tzeng","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104898_bib114","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039179","article-title":"PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model","volume":"7","author":"Tzeng","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2020.104898_bib115","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1073\/pnas.0409028102","article-title":"Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs","volume":"102","author":"Uprichard","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104898_bib116","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1365-2893.2010.01302.x","article-title":"Sequential control of hepatitis B virus in a mouse model of acute, self-resolving hepatitis B","volume":"18","author":"von Freyend","year":"2011","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.antiviral.2020.104898_bib117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.510240101","article-title":"Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo","volume":"24","author":"Walter","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104898_bib118","first-page":"21","article-title":"[Human hepatitis B virus infection of tree shrews and Macaca assamensis in vivo]","volume":"17","author":"Wang","year":"2003","journal-title":"Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology"},{"key":"10.1016\/j.antiviral.2020.104898_bib119","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1053\/j.gastro.2011.01.001","article-title":"A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease","volume":"140","author":"Washburn","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2020.104898_bib120","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/jvi.32.1.314-322.1979","article-title":"Serological relationship of woodchuck hepatitis virus to human hepatitis B virus","volume":"32","author":"Werner","year":"1979","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104898_bib121","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021469","article-title":"The chimpanzee model for hepatitis B virus infection","volume":"5","author":"Wieland","year":"2015","journal-title":"Cold Spring Harbor perspectives in medicine"},{"key":"10.1016\/j.antiviral.2020.104898_bib122","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.scr.2014.08.006","article-title":"Extensive double humanization of both liver and hematopoiesis in FRGN mice","volume":"13","author":"Wilson","year":"2014","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.antiviral.2020.104898_bib123","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/1873-3468.12157","article-title":"In vivo models of hepatitis B and C virus infection","volume":"590","author":"Winer","year":"2016","journal-title":"FEBS Lett."},{"key":"10.1016\/j.antiviral.2020.104898_bib124","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aap9328","article-title":"Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection","volume":"10","author":"Winer","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2020.104898_bib125","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1073\/pnas.91.2.674","article-title":"Establishment and characterization of differentiated, nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor alpha","volume":"91","author":"Wu","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104898_bib126","series-title":"A Novel Recombinant cccDNA-Based Mouse Model with Long Term Maintenance of rcccDNA and Antigenemia","first-page":"104826","author":"Wu","year":"2020"},{"key":"10.1016\/j.antiviral.2020.104898_bib127","doi-asserted-by":"crossref","first-page":"7977","DOI":"10.1128\/JVI.03540-12","article-title":"Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptide","volume":"87","author":"Yan","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104898_bib128","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"eLife"},{"key":"10.1016\/j.antiviral.2020.104898_bib129","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF01261404","article-title":"Human hepatitis B virus and hepatocellular carcinoma. I. Experimental infection of tree shrews with hepatitis B virus","volume":"122","author":"Yan","year":"1996","journal-title":"J. Canc. Res. Clin. Oncol."},{"key":"10.1016\/j.antiviral.2020.104898_bib130","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jhep.2017.02.004","article-title":"HBVcircle: a novel tool to investigate hepatitis B virus covalently closed circular DNA","volume":"66","author":"Yan","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104898_bib131","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/cmi.2013.43","article-title":"A mouse model for HBV immunotolerance and immunotherapy","volume":"11","author":"Yang","year":"2013","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.antiviral.2020.104898_bib132","doi-asserted-by":"crossref","first-page":"13825","DOI":"10.1073\/pnas.202398599","article-title":"Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection","volume":"99","author":"Yang","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104898_bib133","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1073\/pnas.0913498107","article-title":"Immune effectors required for hepatitis B virus clearance","volume":"107","author":"Yang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104898_bib134","series-title":"American College of Laboratory Animal Medicine Series","article-title":"Nonhuman primates in biomedical research, volume 1: biology and management and volume 2: diseases","author":"Yoder","year":"2013"},{"key":"10.1016\/j.antiviral.2020.104898_bib135","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1136\/gutjnl-2018-316091","article-title":"HBV infection-induced liver cirrhosis development in dual-humanised mice with human bone mesenchymal stem cell transplantation","volume":"68","author":"Yuan","year":"2019","journal-title":"Gut"},{"issue":"Suppl. l","key":"10.1016\/j.antiviral.2020.104898_bib136","first-page":"S460","article-title":"Animal models for the study of HBV infection and the evaluation of new anti-HBV strategies","volume":"17","author":"Zoulim","year":"2002","journal-title":"J. Gastroenterol. Hepatol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220303120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220303120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:32:46Z","timestamp":1759062766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354220303120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":134,"alternative-id":["S0166354220303120"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104898","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Animal models for the study of human hepatitis B and D virus infection: New insights and progress","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104898","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104898"}}